Heparin-coating opens new chapter in stenting
This article was originally published in Clinica
Executive Summary
The launch earlier this month of a heparin-coated stent by Medtronic opens a new chapter in the short, meteoric history of stenting. It promises to cut drastically the complications associated with stent implantation and free the patient from aggressive treatment with anticoagulant drugs.